[Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin)]

Praxis (Bern 1994). 2003 Jun 18;92(25-26):1177-84. doi: 10.1024/0369-8394.92.25.1177.
[Article in German]

Abstract

In a clinical multicenter observational study including 584 women attended by 99 participating gynaecologists the quality of life changes after 3 month use of an oral contraceptive preparation containing 30 mcg ethinylestradiol (EE) and 3 mg drospirenone was evaluated through the use of a self developed questionnaire using 20 items with a 5 scale answer scheme. We found a mean positive change of life quality of 7.3%. Significant changes were observed regarding subjective experiences of weight, skin, hair, cycle, attractivity, libido and mental wellbeing.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract
  • Multicenter Study

MeSH terms

  • Adult
  • Androstenes* / administration & dosage
  • Body Weight
  • Contraceptives, Oral* / administration & dosage
  • Data Interpretation, Statistical
  • Ethinyl Estradiol* / administration & dosage
  • Female
  • Follow-Up Studies
  • Humans
  • Libido
  • Menstruation
  • Progesterone Congeners* / administration & dosage
  • Quality of Life*
  • Surveys and Questionnaires
  • Time Factors

Substances

  • Androstenes
  • Contraceptives, Oral
  • Progesterone Congeners
  • Ethinyl Estradiol
  • drospirenone